BRIEF-Emergent BioSolutions files shelf registration -
EBS: To Present At Rodman & Renshaw Investment Conference @ 14:00 ET [delayed] -
Emergent BioSolutions Rallies On Q3 EPS News -
XplosiveStocks.com: Emergent BioSolutions Inc. (NYSE:EBS) Xplosive Stock on the Move! -
BRIEF-Emergent BioSolutions reports Q3 results -
Emergent BioSolutions Reports Financial Results for Third Quarter and First Nine Months of 2008 -
EBS: Q3 Earnings Call @ 16:30 ET Today [delayed] -
Anthrax vaccine manufacturer salvages contest portfolios -
Indices Come Sharply Off their Lows, But The Bleeding Continues -
Emergent BioSolutions Hits Highest Level In Over A Year On Increased Volume -
Emergent BioSolutions Closes At Highest Level In Over A Year -
EBS: US Govt to Purchase Additional 14.5M Doses of BioThrax(R) -
Emergent BioSolutions signs $29.7 million contract with BARDA/NIAID -
EBS: $29.7M Development Contract for AV7909 Anthrax Vaccine -